Question: What information do we know about MIS-C?

Answer passage (source: CDC):
page_title: For Parents: Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
section_headers: What CDC is doing to learn more
section_content: CDC has a team dedicated to investigate MIS-C and gather and communicate
information quickly to healthcare providers, parents and caregivers, as well
as state and local health departments. The team is working with U.S. and
international scientists, healthcare providers, and other partners to learn
more about this new syndrome. They are learning about how often it happens and
who is likely to get it, creating a system to track cases, and providing
guidance to parents and healthcare providers.
Some of the specific actions CDC has taken:

Released a Health Advisory on May 14, 2020, through the Health Alert Network. In this advisory, CDC alerted healthcare providers about MIS-C, issued the case definition that it developed with the Council of State, Tribal, and Territorial Epidemiologists, and recommended that healthcare providers report suspected cases of MIS-C to local, state, or territorial health departments. The information the clinicians and health departments provide will help us understand this new condition and how common it is.
Collaborated with public health agencies around the world to share information and knowledge about cases of MIS-C in other countries.
Sent a field team to New York, the first state to report cases of MIS-C, to help health officials investigate the cases.
Set up a method for state and local health departments to report cases of MIS-C .
Asked clinical research and surveillance networks at children’s hospitals that we work with to collect data on cases of MIS-C.
Began communicating information about what we know, what we don’t know, and what we are doing to learn more to support healthcare providers, parents, and caregivers.
Collaborated with other federal agencies, clinical, and professional societies.


Reviewer feedback on this answer:
It talks about the disease and what steps are being taken, but nothing is said about what the disease actually is.
This answer does not provide any information on the MIS-C itself, instead, this information explains what specific actions had been taken by CDC to find out more about MIS-C.

Reviewer ratings:
Could be Improved
Bad

Answer passage (source: CDC):
page_title: Frequently Asked Questions
section_headers: COVID-19 and Children
What is multisystem inflammatory syndrome in children (MIS-C) and who is at risk?
section_content: CDC is working with state and local health departments to investigate reports
of multisystem inflammatory syndrome in children (MIS-C) associated with
COVID-19 and gather more information as quickly as possible about how common
it is and who is at risk. As new information becomes available, we will
continue to provide information for parents and caregivers as well as
healthcare and public health professionals. MIS-C has been described as
inflammation (swelling) across multiple body systems, potentially including
the heart, lungs, kidneys, brain, skin, eyes, and gastrointestinal organs.
Signs and symptoms of MIS-C include fever and various symptoms such as
abdominal pain, vomiting, diarrhea, neck pain, rash, and feeling tired.
If your child has any of these symptoms, other symptoms of
COVID-19, or other
concerning signs, contact your pediatrician. If your child is showing any
emergency warning signs including trouble breathing, persistent pain or
pressure in the chest, new confusion, inability to wake or stay awake, bluish
lips or face, severe abdominal pain, or other concerning signs, seek
emergency care right away.

Reviewer feedback on this answer:
The answer talks about the condition and it says what exactly it is.
This answers the question directly. This answer provides information of what is currently known about MIS-C, which is inflammation across multiple body systems and organs as well as the signs and symptoms of MIS-C.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Testing, Diagnosis, and Notification
How do you diagnose and report a potential case of multisystem inflammatory syndrome in children (MIS-C)?
section_content: Patients with MIS-C have presented with a persistent fever and a variety of
signs and symptoms including multiorgan (e.g., cardiac, gastrointestinal,
renal, hematologic, dermatologic, neurologic) involvement and elevated
inflammatory markers. Not all children will have the same symptoms. For
children who may have MIS-C, further evaluation for signs of this syndrome may
include (but are not limited to) chest radiograph, echocardiography, and blood
testing to evaluate for evidence of inflammation.
Healthcare providers who have cared or are caring for patients younger than 21
years of age meeting MIS-C criteria should report suspected cases to their
local, state, or territorial health department. After hour phone numbers for
health departments are available at the Council of State and Territorial
Epidemiologists website.external
icon For additional reporting
questions, please contact CDC’s 24-hour Emergency Operations Center at
770-488-7100. For more information, including a full case definition, please
visit the CDC Health Alert
Network. For guidance for
pediatric healthcare providers, visit Information for Pediatric Healthcare
Providers.

Reviewer feedback on this answer:
The answer addresses the condition and lists symptoms that come along with having it.
This answer provides what is currently known regarding the MIS-C such as the sign and symptoms of MIS-C. This answer also provides information on methods of evaluation for the illness and what healthcare providers should do if there is suspected case of MIS-C in patient under their care.

Reviewer ratings:
Excellent
Excellent